0000899243-20-011298.txt : 20200424 0000899243-20-011298.hdr.sgml : 20200424 20200424165951 ACCESSION NUMBER: 0000899243-20-011298 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200207 FILED AS OF DATE: 20200424 DATE AS OF CHANGE: 20200424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Societe des Produits Nestle S.A. CENTRAL INDEX KEY: 0001803539 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37519 FILM NUMBER: 20815825 BUSINESS ADDRESS: STREET 1: AVENUE NESTLE 55 CITY: VEVEY STATE: V8 ZIP: CH-1800 BUSINESS PHONE: 41-21-924-1111 MAIL ADDRESS: STREET 1: AVENUE NESTLE 55 CITY: VEVEY STATE: V8 ZIP: CH-1800 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NESTLE SA CENTRAL INDEX KEY: 0000792990 STANDARD INDUSTRIAL CLASSIFICATION: FOOD & KINDRED PRODUCTS [2000] FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37519 FILM NUMBER: 20815826 BUSINESS ADDRESS: STREET 1: AVE NESELE 55, CH-1800 CITY: VEVEY STATE: V8 BUSINESS PHONE: 01141219241111 MAIL ADDRESS: STREET 1: AVE NESTLE 55 STREET 2: CH-1800 CITY: VEVEY STATE: V8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aimmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001631650 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452748244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BOULEVARD STREET 2: SUITE 300 CITY: BRISBANE STATE: CA ZIP: 94005-1884 BUSINESS PHONE: (650) 614-5220 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD STREET 2: SUITE 300 CITY: BRISBANE STATE: CA ZIP: 94005-1884 FORMER COMPANY: FORMER CONFORMED NAME: Allergen Research Corp DATE OF NAME CHANGE: 20150123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-07 0 0001631650 Aimmune Therapeutics, Inc. AIMT 0001803539 Societe des Produits Nestle S.A. AVENUE NESTLE 55 CH-1800, VEVEY V8 SWITZERLAND 0 0 1 0 0000792990 NESTLE SA AVENUE NESTLE 55 CH-1800, VEVEY V8 SWITZERLAND 0 0 1 0 Common Stock 2020-02-07 4 P 0 1000000 31.97 A 12727113 I See Footnote Series A Preferred Stock 2020-02-07 4 P 0 525634 319.675 A 525634 I See Footnote Common Stock 2020-04-22 4 J 0 12727113 16.11 A 12727113 I See Footnote Series A Preferred Stock 2020-04-22 4 J 0 525634 161.10 A 525634 I See Footnote Consists of 12,727,113 shares of Common Stock held by Nestle Health Science US Holdings, Inc. ("NHS"). NHS is a wholly owned subsidiary of NIMCO US, Inc. ("NIMCO"). NIMCO, in turn, is a wholly-owned subsidiary of Nestle US Holdco, Inc. ("Nestle US Holdco"), which is a wholly-owned subsidiary of Societe des Products Nestle S.A.("SPN"). The ultimate parent company of NHS, NIMCO, Nestle US Holdco and SPN is Nestle S.A. ("Nestle"). Following the purchase referred to in the table above and prior to the internal transfer referred to in Note 3 below, each of these entities may be deemed to share voting and investment power with respect to all shares of Common Stock held by NHS. Each of NIMCO, Nestle US Holdco, SPN and Nestle disclaims beneficial ownership of such shares of Common Stock except to the extent of its pecuniary interest therein. Consists of 525,634 shares of Series A Preferred Stock held by NHS with each share of Series A Preferred Stock convertible into ten shares of Common Stock. Following the purchase and prior to the internal transfer referred to in Note 3 below, each of NHS, NIMCO, Nestle US Holdco, SPN and Nestle may be deemed to share voting and investment power with respect to these shares of Series A Preferred Stock held by NHS. Each of NIMCO, Nestle US Holdco, SPN and Nestle disclaims beneficial ownership of such shares of Series A Preferred Stock except to the extent of its pecuniary interest therein. This transaction constitutes an internal transfer of 12,727,113 shares of Common Stock and 525,634 shares of Series A Preferred Stock from NHS to SPN. Following the transfer, SPN and Nestle may be deemed to share voting and investment power with respect to all shares of Common Stock and Series A Preferred Stock. Nestle disclaims beneficial ownership of such shares of Common Stock and Series A Preferred Stock except to the extent of its pecuniary interest therein. Subsequent to this internal transfer, each of NHS, NIMCO, and Nestle US Holdco no longer hold any shares of Common Stock or Series A Preferred Stock and are therefore no longer Reporting Owners. NESTLE HEALTH SCIENCE US HOLDINGS, INC. By: Name: James Pepin, Title: Director and President 2020-04-24 NIMCO US, INC. By: Name: Dan Nugent, Title: Chief Legal Officer and General Counsel 2020-04-24 NESTLE US HOLDCO, INC. By: Name: Michael Prewitt, Title: Secretary 2020-04-24 SOCIETE DES PRODUITS NESTLE S.A. By: Name: Claudio Kuoni, Title: Vice President 2020-04-24 NESTLE S.A. By: Name: Gregory Behar, Title: Deputy Executive Vice President 2020-04-24